[go: up one dir, main page]

WO1999024600A1 - Process for preparing sugar nucleotide - Google Patents

Process for preparing sugar nucleotide Download PDF

Info

Publication number
WO1999024600A1
WO1999024600A1 PCT/JP1998/004895 JP9804895W WO9924600A1 WO 1999024600 A1 WO1999024600 A1 WO 1999024600A1 JP 9804895 W JP9804895 W JP 9804895W WO 9924600 A1 WO9924600 A1 WO 9924600A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar
monophosphate
kinase
galactose
phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP1998/004895
Other languages
French (fr)
Japanese (ja)
Inventor
Toshitada Noguchi
Kazuhiro Abe
Yutaka Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Corp
Original Assignee
Yamasa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Corp filed Critical Yamasa Corp
Publication of WO1999024600A1 publication Critical patent/WO1999024600A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides

Definitions

  • the present invention relates to a novel method for producing sugar nucleotides, which are important substrates for sugar chain synthesis.
  • oligosaccharides have been produced by extraction from natural products, chemical synthesis, or enzyme synthesis, or a combination of these methods.
  • Enzyme synthesis is considered to be a suitable method for mass production. Have been. In other words, (1) the enzyme synthesis method does not require complicated procedures such as protection and deprotection found in the chemical synthesis method, and the desired oligosaccharide can be synthesized quickly. (2) Due to the substrate specificity of the enzyme, This method is considered to be advantageous over other methods in that it can synthesize oligosaccharides with extremely high structure specificity, etc.
  • various synthases can be produced at low cost and in large quantities. The ability to do so has further enhanced the advantages of enzyme synthesis.
  • a method for synthesizing oligosaccharide by an enzyme synthesis method two methods, a method using a reverse reaction of an oligosaccharide hydrolase and a method using a glycosyltransferase are considered.
  • the former method is based on the fact that low-cost monosaccharides can be used as substrates.
  • the reaction itself utilizes the reverse reaction of the decomposition reaction, and is not necessarily considered to be the best method in terms of the synthesis yield and application to oligosaccharides with complex structures. .
  • the latter is a synthesis method using a glycosyltransferase, and is considered to be more advantageous than the former method in terms of synthesis yield and application to oligosaccharides having a complicated structure.
  • the mass production of various glycosyltransferases is also pushing the realization of this technology.
  • the present inventors have conducted research to find a simple and practical method of UDP-G a £.
  • galactokinase synthesizes galactose monophosphate from galactose.
  • UDP-Ga are efficiently synthesized by a two-step process consisting of a reaction that chemically reacts the prepared galactose-monophosphate with peridine 5'-monophosphate (UMP).
  • UMP peridine 5'-monophosphate
  • the present inventors have found that the method can be performed, and further confirmed that the method is not limited to the production of UDP-Ga ⁇ but can be applied to the production of other sugar nucleotides, thereby completing the present invention.
  • the present invention provides a method for phosphorylating a sugar using a kinase to prepare a sugar monophosphate, and converting a sugar nucleotide from the obtained sugar 1-phosphate and nucleoside 5′-monophosphate by a chemical condensation method.
  • the present invention relates to a method for producing a sugar nucleotide, characterized by being prepared.
  • the kinase used in the present invention is not particularly limited as long as the sugar 1-phosphate can be prepared from a phosphate donor such as adenosine 5'-triphosphate (ATP) and a sugar.
  • a phosphate donor such as adenosine 5'-triphosphate (ATP) and a sugar.
  • Illustrative examples include, but are not limited to, enzyme, glucuronokinase, galacturonokinase, arabinokinase, and fucokinase.
  • the origin of the kinase is not limited to a specific origin such as animal origin, plant origin, or microbial origin, and any origin can be used. However, it is convenient to use an enzyme derived from a microorganism from the viewpoint of simplicity of enzyme preparation.
  • the kinase added to the reaction system may be in any form as long as it has the activity. Specific examples include microbial cells, processed products of the microbial cells, enzyme preparations obtained from the processed products, and the like.
  • the cells of the microorganism can be prepared by using a medium in which the microorganism can grow, culturing by a conventional method, and collecting cells by centrifugation or the like.
  • the culture medium may be broth medium, LB medium (1% tryptone, 0.5% first extract, 1% salt) or 2XYT medium (1.6% Triton, 1% yeast extract, 0.5% salt) can be used.After inoculating the culture medium with the inoculum, stir at 30 to 50 ° C for about 10 to 50 hours if necessary.
  • Microbial cells having kinase activity can be prepared by centrifuging the obtained culture solution and collecting the microbial cells.
  • Microbial cell processed products include mechanical destruction of the above microbial cells (using a Waring blender, French press, homogenizer, mortar, etc.), freeze-thawing, self-digestion, drying (freeze-drying, air-drying, etc.), enzymes Destruction of cells or denaturation of cell walls or cell membranes obtained by treatment according to general treatment methods such as treatment (eg, with lysozyme), ultrasonic treatment, or chemical treatment (eg, with acid or alkali). Can be exemplified.
  • a fraction having the enzyme activity from the treated cells is purified by a conventional enzyme purification method (salt-out treatment, isoelectric point precipitation, organic solvent precipitation, dialysis, various types of chromatography) And the like).
  • sugar used in the present invention examples include galactose, glucuronic acid, galacturonic acid, arabinose, fucose and the like depending on the target sugar nucleotide. These can use a commercial thing.
  • concentration used can be appropriately set within a range of about 1 to 200 mM, preferably about 10 to 10 OmM.
  • ATP can be used as a phosphoric acid donor.
  • ATP may also be a commercially available product, and the concentration used can be appropriately set in the range of about 1 to 20 OmM, preferably about 10 to 10 OmM, corresponding to the sugar concentration. Since ATP is generally expensive, an ATP regeneration system using polyphosphate kinase using polyphosphate as a phosphate donor can also be used.
  • inorganic ions corresponding to enzymes such as magnesium ion and zinc ion are added in the range of about 5 to 2 OmM in addition to the above kinase, sugar and ATP or ATP regeneration system, and the pH is adjusted to about pH. It can be carried out in a suitable buffer in the range of 5.0 to 9.0 at about 10 to 50 ° C, preferably in the range of 30 to 40 ° C.
  • the sugar 1-phosphate thus obtained can be easily isolated and purified by ordinary isolation and purification means (eg, ion exchange chromatography, adsorption chromatography, salting out, etc.).
  • isolation and purification means eg, ion exchange chromatography, adsorption chromatography, salting out, etc.
  • the chemical condensation reaction between sugar 1-phosphate and nucleoside 5'-monophosphate may be carried out according to a known method. Specifically, a method using dicyclohexyl carpoimide (DCC) (Am. Chem. So, 80, 3756 (1958)), a morpholidate method (Am. Chem. So, 83, 659 (1961)) , Anion exchange method (Biochim. Biopys. Acta, 91, 1-13 (1964), Japanese Patent Publication No. 49-10674, Japanese Patent Publication No. 51-39227), etc. Among them, the anion exchange method is particularly preferable.
  • the reaction conditions and the like for the condensation reaction may be performed according to the description in the above-mentioned literature.
  • the sugar nucleotide thus obtained can be isolated and purified by ordinary isolation and purification means (eg, ion exchange chromatography, adsorption chromatography, salting out, etc.).
  • isolation and purification means eg, ion exchange chromatography, adsorption chromatography, salting out, etc.
  • isopropyl-D-thiogalactobilanoside was added to a final concentration of 0.5 mM, and shaking culture was continued for further 5 hours at 30 ° C.
  • the cells are collected from the culture by centrifugation, suspended in 5 Om ⁇ buffer (5 OmM Tris-HCl (pH 7.8), 1 mM EDTA), and then disrupted by sonication. Was crushed. The supernatant obtained by centrifugation was used as an enzyme solution.
  • the recovered 5 Om crude enzyme solution contained 15 units / m of galactokinase activity, and the activity per protein was 1.3 units / mg.
  • the unit of activity (unit) is measured and calculated by the following method.
  • Tris-HCl buffer pH 7.8 containing 5 mM magnesium chloride, 1 OmM galactose, and 10 mM ATP.
  • the enzyme After incubating at 37 ° C, the enzyme is inactivated by heat treatment at 100 ° C for 1 minute. Quantify the concentration of galactose 1-phosphate in the reaction solution using a DI ONEX sugar analyzer. Under these conditions, 1 micromol of galactose-monophosphate per minute The generated activity was defined as one unit.
  • the reaction rate was confirmed with a Dionex sugar analyzer, and after 2 hours and 30 minutes, the enzyme reaction was stopped when the temperature reached 80 ° C.
  • the denatured protein precipitate was filtered off by 3.0 ⁇ MF filtration to obtain 2.2 £ of an enzyme reaction solution.
  • Galactose 1-phosphate potassium salt was dissolved in water, and this was subjected to cation exchange resin column chromatography and washed with water. Tributylamine was added to the obtained passing and washing solution, neutralized by stirring, and then concentrated under reduced pressure. After drying, pyridine was added to redissolve and concentrated under reduced pressure. Further, pyridine was added again and redissolved to obtain a pyridine solution of Ga_g-1 -—- tri- ⁇ -butylamine.
  • the synthesis solution thus obtained was diluted, applied to an anion-exchange resin, Lamchromatography, washed with water, and eluted UDP-Ga ⁇ with a NaC solution.
  • the obtained UDP-Ga fraction was adjusted to pH 3.0 by adding 1 N hydrochloric acid, passed through a granular activated carbon column, washed with water, and eluted with a NaOH solution.
  • the fractions containing UDP-Ga ⁇ in the water washing and eluate were collected, adjusted to pH 6.2, and concentrated under reduced pressure. Alcohol was added to this solution to precipitate UDP-Ga ⁇ .
  • the supernatant was removed by decantation, and the precipitate was dissolved in water. After concentration under reduced pressure, the residue was freeze-dried to obtain 22.4 g of UDP-Ga_g.
  • Chromosomal DNA of Escherichia coli K12 strain JM109 was prepared by the method of Saito and Miura (Biochim. Biophys. Acta., 72, 619 (1963)).
  • this DNA was synthesized according to a conventional method, and the Escherichia coli polyphosphate kinase (ppk) gene was amplified by PCR.
  • Amplification of the ppk gene by PCR is performed in a reaction mixture of 10 Om ⁇ (5 OmM chloride, 1 OmM Tris-HCl (pH 8.3), 1.5 mM magnesium chloride, 0.01% gelatin, temperate 0.1 ⁇ g of DNA, 0.2 ⁇ M each of primer DNA (A) and (B), 2.5 units of Ampli Taq DNA polymerase) were added to Perkin—ElmerCetus Instrument Thermal denaturation (94 ° C, 1 minute), annealing (55 ° C, 1.5 minutes), polymerase (72 ° (1.5 minutes)) using DNA Thermal Cyc 1 er ) Was repeated 25 times.
  • the reaction solution was treated with a mixed solution of phenol Z-cloth form (1: 1), and two times the volume of ethanol was added to the water-soluble fraction to precipitate DNA.
  • the DNA collected by precipitation was separated by agarose gel electrophoresis according to the method described in the literature (Molecular Cloning, supra), and a DNA fragment corresponding to 1.0 kb was purified.
  • the DNA was digested with restriction enzymes NcoI and BamHI and ligated with plasmid pTrc99A (obtained from Pharmacia Biotech), also digested with restriction enzymes NcoI and BamHI, using T4 DNA ligase. .
  • Escherichia coli JM109 was transformed using the ligation reaction solution, and plasmid pTrc-PPK was isolated from the obtained ampicillin-resistant transformant.
  • pTr c -PPK is obtained by inserting an Nco I -BamHI DNA fragment containing the E. coli ppk gene into the Nco I -BamHI cleavage site downstream of the "trc promoter of pTr c 99A.
  • Escherichia coli JM109 carrying the plasmid pTrc-PPK was inoculated into 2Om ⁇ of a 2 x YT medium containing 100 ⁇ g of ampicillin and cultured with shaking at 37 ° C.
  • 4 X 1 0 8 bacteria Zm ⁇ was added I PTG to a final concentration of 1 mM to the culture solution was continued for an additional 5 hours with shaking cultured at 30 ° C.
  • the cells were collected by centrifugation (9,000 xg, 10 minutes), and a 60-m buffer (50 mM Tris-HCl ( ⁇ 7.5), 5 mM EDTA, 0.1% Triton X-100, 0.2 mgZm lysozyme).
  • the cells were sonicated to disrupt the cells, and centrifuged (20,000 xg, 10 minutes) to remove the cell residues.
  • the supernatant fraction thus obtained was dialyzed against 5 OmM Tris-HCl (pH 7.8) containing 5 mM magnesium chloride and 1 mM 2-mercaptoethanol to obtain a crude enzyme solution.
  • the specific activity of polyphosphate kinase in the crude enzyme solution is 0.19 units / mg protein, which is the specific activity of the control bacterium (Escherichia coli JM109 carrying pTrc99A).
  • polyphosphate kinase (0.00000 unit mg protein).
  • the crude enzyme solution was fractionated using DEAE Toyopearl 65 M (Tosoichi Co., Ltd.) with a concentration gradient of 0 to 0.5 M NaCp to obtain a polyphosphate kinase fraction.
  • This fraction was used as a polyphosphate kinase enzyme preparation.
  • the specific activity of polyphosphate kinase in this enzyme preparation was 0.6 unit / mg protein.
  • Chromosomal DNA of Escherichia coli 12 strain JM109 was prepared by the method of Saito and Miura (Biochim. Biophys. Acta., 72, 619 (1963)).
  • this DNA was synthesized according to a conventional method, and the E. coli adenylate tokinase (adk) gene was amplified by PCR.
  • the amplification of the adk gene by PCR was performed in a reaction mixture of 1 O Om ⁇ (50 mM chloride, 1 OmM tris-hydrochloride ( ⁇ 8.3), 1.5 mM magnesium chloride, 0.01% gelatin, Belate DNA 0.1 g, Primer DNA (C) (D) 0.1 M each, Ampli Taq DNA polymerase 2.5 units> 3 ⁇ 4rPerkin—ElmerCet ⁇ S I Thermal denaturation (94 ° C, 1 minute), annealing (56 ° C, 1.0 minute), polymerase (72 ° C) using DNA Thermal Cyc 1 er manufactured by nstrument (C, 3.0 minutes) was repeated 25 times.After gene amplification, the reaction solution was treated with a mixture of phenol Z-cloth form (1: 1) and doubled to the water-soluble fraction.
  • the precipitated DNA was separated by agarose gel electrophoresis according to the method described in the literature (Molecular cloning, described above), and the DNA was precipitated. A DNA fragment corresponding to kb was purified. The DNA was cleaved with restriction enzymes BamHI and Hind1, and plasmid pUC18 (obtained from Takara Shuzo Co., Ltd.) and T4DNA ligase digested with restriction enzymes BamHI and Hindill were also used. Connected. Escherichia coli JM109 was transformed using the ligation reaction solution, and plasmid pUC-ADK was isolated from the resulting ampicillin-resistant transformant. pUC-ADK is obtained by inserting a BamHI-HindI DNA fragment containing the E. coli adk gene into the BamHI-HindIE cleavage site downstream of the 1 ac promoter of pUC18.
  • Escherichia coli JM109 carrying plasmid pUC-ADK was inoculated into 30 Om ⁇ of 2 x YT medium containing 100 ⁇ g of ampicillin, and cultured at 37 ° C with shaking. When the culture reached 4 ⁇ 10 8 Zm, IPTG was added to the culture solution to a final concentration of ImM, and shaking culture was further continued at 30 ° C. for 5 hours. After completion of the culture, the cells were collected by centrifugation (9,000 xg, 10 minutes), and a 60-m buffer (50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 0.1% Triton X—100 , 0.2 mg Zm ⁇ lysozyme). After incubating for 1 hour at 37, the cells were sonicated to disrupt the cells, and centrifuged (20,000 xg, 10 minutes) to remove cell residues.
  • a 60-m buffer 50 mM Tris-HCl (pH 7.5), 5 mM
  • the supernatant fraction thus obtained was dialyzed against 5 OmM Tris-HCl (pH 7.8) containing 5 mM magnesium chloride and ImM2-mercaptoethanol to obtain a crude enzyme solution.
  • the specific activity of adenylate kinase in the crude enzyme solution is 134 units Zmg protein, which is about the same as the specific activity (1.9 units / mg protein) of the control bacterium (Escherichia coli JM109 carrying pUC18). It was 85 times.
  • the crude enzyme solution was fractionated using DEAE Toyopearl 650 M (Tosoichi Co., Ltd.) with a concentration gradient of 0.5 to 0.5 M Na, and a fraction having adenylate kinase activity was collected. This fraction was used as an adenylate kinase enzyme preparation.
  • this enzyme preparation The specific activity of polyphosphate kinase in was 344 units / mg protein.c
  • 0.1 unit / polyphosphoric acid in 100 mM Tris-HCl buffer (pH 7.8) containing 1 OmM magnesium chloride, 10 OmM ammonium sulfate, polyphosphoric acid (75 mM as inorganic phosphoric acid) and 4 mM AMP Acid kinase and 2.5 units of Zm ⁇ T denylate kinase enzyme preparation were added, and the mixture was incubated at 37 ° C for 120 minutes.
  • the nucleotide concentrations in the reaction solution at the end of the AMP phosphorylation reaction were ATP 1.4 m, ADP 1.7 mM, and AMP 0.9 mM.
  • the desired sugar 1-monophosphate can be prepared simply and in good yield, and Sugar monophosphate can be easily isolated and purified by simple means, and high purity sugar 1-phosphate can be obtained.
  • a chemical condensation reaction is performed using such high-purity sugar 1-phosphate, the target sugar nucleotide can be obtained in good yield, and the obtained sugar nucleotide can be easily isolated and purified. .
  • the method of the present invention can be said to be a practical and practical method for sugar nucleotides.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

A process for preparing a sugar nucleotide, characterized by phosphorylating a sugar with a kinase to prepare a sugar 1-phosphate and effecting chemical condensation between the sugar 1-phosphate and a nucleoside 5'-monophosphate. The target sugar nucleotide can be obtained in a high yield and can be isolated and purified readily.

Description

明 細 書 糖ヌクレオチドの製造方法  Description Method for producing sugar nucleotides

技術分野 Technical field

本発明は、 糖鎖合成の重要な基質である糖ヌクレオチドの新規な製造法に関す るものである。  The present invention relates to a novel method for producing sugar nucleotides, which are important substrates for sugar chain synthesis.

背景技術 Background art

近年、 糖鎖についての研究が急速に進み、 その機能が明らかになるにつれ、 生 理活性を有するオリゴ糖の医薬品または機能性素材としての用途開発が注目を集 めている。 し力、し、 現在市販されているオリゴ糖はごく限られた種類のものしか なく、 しかも極めて高価である。 また、 そのようなオリゴ糖は試薬レベルでしか 製造できず、 必ずしもその大量製造法が確立されているとは限らない。  In recent years, research on sugar chains has progressed rapidly, and as their functions have been elucidated, the development of applications of bioactive oligosaccharides as pharmaceuticals or functional materials has attracted attention. However, there are only a limited number of oligosaccharides on the market today, and they are extremely expensive. In addition, such oligosaccharides can be produced only at the reagent level, and a method for mass-producing them is not always established.

従来、 オリゴ糖の製造は天然物からの抽出法、 化学合成法あるいは酵素合成法、 さらにはそれらの併用により行われていたが、 その中でも酵素合成法が大量製造 に適した方法であると考えられている。 すなわち、 ( 1〕 酵素合成法が化学合成 法にみられる保護、 脱保護といった煩雑な手順を必要とせず、 速やかに目的のォ リゴ糖を合成できる点、 (2 ) 酵素の基質特異性により、 きわめて構造特異性の 高いオリゴ糖を合成できる点などが他の方法より有利と考えられるためである。 さらに、 近年の D NA組換え技術の発達により種々の合成酵素が安価にしかも大 量に生産できるようになりつつあることが、 酵素合成法の優位性をさらに押し上 げる結果となっている。  Conventionally, oligosaccharides have been produced by extraction from natural products, chemical synthesis, or enzyme synthesis, or a combination of these methods.Enzyme synthesis is considered to be a suitable method for mass production. Have been. In other words, (1) the enzyme synthesis method does not require complicated procedures such as protection and deprotection found in the chemical synthesis method, and the desired oligosaccharide can be synthesized quickly. (2) Due to the substrate specificity of the enzyme, This method is considered to be advantageous over other methods in that it can synthesize oligosaccharides with extremely high structure specificity, etc. In addition, with the development of DNA recombination technology in recent years, various synthases can be produced at low cost and in large quantities. The ability to do so has further enhanced the advantages of enzyme synthesis.

酵素合成法によりォリゴ糖を合成する方法としては、 ォリゴ糖の加水分解酵素 の逆反応を利用する方法および糖転移酵素を利用する方法の 2通りの方法が考え られている。 前者の方法は、 基質として単価の安い単糖を用いることができると いう利点はあるものの、 反応自体は分解反応の逆反応を利用するものであり、 合 成収率や複雑な構造を持つォリゴ糖合成への応用といった点では必ずしも最良の 方法とは考えられていない。 As a method for synthesizing oligosaccharide by an enzyme synthesis method, two methods, a method using a reverse reaction of an oligosaccharide hydrolase and a method using a glycosyltransferase are considered. The former method is based on the fact that low-cost monosaccharides can be used as substrates. Despite the advantages mentioned above, the reaction itself utilizes the reverse reaction of the decomposition reaction, and is not necessarily considered to be the best method in terms of the synthesis yield and application to oligosaccharides with complex structures. .

一方、 後者は糖転移酵素を用いる合成法であり、 合成収率や複雑な構造を持つ ォリゴ糖合成への応用といつた点で前者の方法よりも有利であると考えられてお り、 また、 近年の DNA組換え技術の進歩により各種糖転移酵素の量産化も該技 術の実現化への後押しとなつている。  On the other hand, the latter is a synthesis method using a glycosyltransferase, and is considered to be more advantageous than the former method in terms of synthesis yield and application to oligosaccharides having a complicated structure. However, with the recent advances in DNA recombination technology, the mass production of various glycosyltransferases is also pushing the realization of this technology.

しかしながら、 糖転移酵素を利用した合成法で用いる糖供与体である糖ヌクレ ォチドは、 一部のものを除き依然として高価で、 量的にも試薬レベルのわずかな 供給量でしか提供し得ないのが現状である。 多くの生理活性糖鎖のコア部分に含 まれるガラクトースの供与体であるゥリジンニリン酸—ガラクトース (UDP— G a i ) についても、 C a n d i d a属酵母を用いる方法 (Proc. IV IFS: Ferment. Technol. Today, p. 463 (1972)、 Agric, Biol. Chem. , 37, 1741 (1973))、 あるいは化学的に合成する方法 (Adv. Carbohydr. Chem. Biochem., 28, 307 (1973)、 Methods Enzymol., 8, 136, (1966、 J. Am. Chem. So , 83, 659 (1961)) などが報告されている。  However, sugar nucleotides, which are sugar donors used in glycosyltransferase-based synthetic methods, are still expensive except for some, and can be provided only in small quantities at reagent level. Is the current situation. Perysin diphosphate-galactose (UDP-Gai), a donor of galactose contained in many bioactive sugar chain cores, was also prepared using a yeast of the genus C andida (Proc. IV IFS: Ferment. Technol. Today) , p. 463 (1972), Agric, Biol. Chem., 37, 1741 (1973)), or a method of chemical synthesis (Adv. Carbohydr. Chem. Biochem., 28, 307 (1973)), Methods Enzymol. , 8, 136, (1966, J. Am. Chem. So, 83, 659 (1961)).

Can d i d a属酵母を用いて UDP - G a を製造する場合、 該酵母菌体の 培養及び乾燥菌体の調製が不可欠であり、 多大な設備と労力が必要であり、 生成 収率も必ずしも満足ゆくものではなかった。 また、 酵母を用いて UDP—グルコ —スを調製し、 これをェピメラ一ゼを用いて UDP— Ga ^に変換する方法も考 えられているが、 ェピメラーゼを用いた変換反応は平衡反応であり、 反応液中に UDP— Ga^と UDP—グルコースが必ず混在することとなり、 両者を分離す ることは極めて困難である。  When producing UDP-Ga using yeast of the genus Can dida, cultivation of the yeast cells and preparation of dried cells are indispensable, requiring a great deal of equipment and labor, and the production yield is not always satisfactory. It was not something. A method of preparing UDP-glucose using yeast and converting it to UDP-Ga ^ using epimerase has also been considered, but the conversion reaction using epimerase is an equilibrium reaction. However, UDP-Ga ^ and UDP-glucose are always mixed in the reaction solution, and it is extremely difficult to separate them.

一方、 化学合成法で UDP— Ga ^を製造する場合、 まずガラクトース 1ーリ ン酸を合成し、 これとゥリジン 5' —モノリン酸を化学的に縮合する方法が一般 的である。 し力、し、 化学的にガラクトース 1―リン酸を合成する場合、 合成収率 が低いばかりでなく、 反応液からガラクト一ス 1 一リン酸のみを単離精製するこ とが極めて困難であった。 また、 純度の低いガラクト一ス 1 一リン酸を次の縮合 反応に用いると反応が良好に進行せず、 得られる糖ヌクレオチドの合成収率は低 く、 その単離も極めて厄介であるといつた欠点を有していた。 発明の開示 On the other hand, when UDP-Ga ^ is produced by a chemical synthesis method, it is common to first synthesize galactose 1-phosphate and then chemically condense it with peridine 5'-monophosphate. When chemically synthesizing galactose 1-phosphate, the synthesis yield Not only low, but also it was extremely difficult to isolate and purify only galactose-monophosphate from the reaction solution. In addition, when low-purity galactose-monophosphate is used in the subsequent condensation reaction, the reaction does not proceed well, the synthesis yield of the resulting sugar nucleotide is low, and its isolation is extremely troublesome. Had disadvantages. Disclosure of the invention

本発明者らは U D P— G a £の簡便で実用的な方法を見いだすべく研究を重ね た結果、 酵素反応と化学反応を組み合わせ、 ガラクトキナ一ゼによりガラクトー スよりガラクト一ス 1 一リン酸を合成する反応と、 調製したガラクト一ス 1 一リ ン酸とゥリジン 5 ' —モノリン酸 (UM P ) を化学的に縮合させる反応とから成 る 2段階の工程により効率的に U D P— G a を合成できることを見出し、 さら にこの方法が U D P - G a ^の製造だけに限定されず、 他の糖ヌクレオチドの製 造に適用できることを確認し、 本発明を完成させた。  The present inventors have conducted research to find a simple and practical method of UDP-G a £. As a result of combining enzymatic reaction and chemical reaction, galactokinase synthesizes galactose monophosphate from galactose. And UDP-Ga are efficiently synthesized by a two-step process consisting of a reaction that chemically reacts the prepared galactose-monophosphate with peridine 5'-monophosphate (UMP). The present inventors have found that the method can be performed, and further confirmed that the method is not limited to the production of UDP-Ga ^ but can be applied to the production of other sugar nucleotides, thereby completing the present invention.

すなわち、 本発明は、 キナーゼを用いて糖をリン酸化して糖 1 一リン酸を調製 し、 得られた糖 1 —リン酸とヌクレオシド 5 ' —モノリン酸から化学的縮合法に より糖ヌクレオチドを調製することを特徴とする、 糖ヌクレオチドの製造方法に 関するものである。 発明を実施するための最良の形態  That is, the present invention provides a method for phosphorylating a sugar using a kinase to prepare a sugar monophosphate, and converting a sugar nucleotide from the obtained sugar 1-phosphate and nucleoside 5′-monophosphate by a chemical condensation method. The present invention relates to a method for producing a sugar nucleotide, characterized by being prepared. BEST MODE FOR CARRYING OUT THE INVENTION

本発明で使用するキナーゼとしては、 アデノシン 5 ' —三リン酸 ( A T P ) な どのリン酸供与体と糖から糖 1—リン酸を調製できるものであれば特に限定され ず、 具体的にはガラクトキナ一ゼ、 グルクロノキナーゼ、 ガラクッロノキナーゼ、 ァラビノキナ一ゼ、 フコキナーゼ等を例示することができる。 キナーゼの由来と しては、 動物由来、 植物由来、 微生物由来など特定の由来のものに限定されず、 すべての由来のものを使用することができる。 しかし、 酵素調製の簡便性などの 点から微生物由来の酵素を使用するのが好都合である。 また、 各種酵素調製の簡 便さと共に調製効率を高めるため、 該酵素遺伝子をクローン化し、 微生物菌体内 で大量発現させ、 該酵素の大量調製を行う、 いわゆる組換え D N A手法を用いた 酵素生産が最も効率がよい。 The kinase used in the present invention is not particularly limited as long as the sugar 1-phosphate can be prepared from a phosphate donor such as adenosine 5'-triphosphate (ATP) and a sugar. Illustrative examples include, but are not limited to, enzyme, glucuronokinase, galacturonokinase, arabinokinase, and fucokinase. The origin of the kinase is not limited to a specific origin such as animal origin, plant origin, or microbial origin, and any origin can be used. However, it is convenient to use an enzyme derived from a microorganism from the viewpoint of simplicity of enzyme preparation. In addition, simple preparation of various enzymes In order to enhance the preparation efficiency as well as the convenience, the enzyme production using the so-called recombinant DNA technique, in which the enzyme gene is cloned, expressed in a large amount in a microbial cell, and the enzyme is prepared in large quantities, is most efficient.

反応系に添加するキナーゼは、 当該活性を有する限りどのような形態であって もよい。 具体的には、 微生物の菌体、 該菌体の処理物または該処理物から得られ る酵素調製物などを例示することができる。  The kinase added to the reaction system may be in any form as long as it has the activity. Specific examples include microbial cells, processed products of the microbial cells, enzyme preparations obtained from the processed products, and the like.

微生物の菌体の調製は、 当該微生物が生育可能な培地を用い、 常法により培養 後、 遠心分離等で集菌する方法で行うことができる。 具体的に、 大腸菌を例に挙 げ説明すれば、 培地としてはブイョン培地、 L B培地 ( 1 %トリプトン、 0 . 5 %ィ一ストエキストラクト、 1 %食塩) または 2 X Y T培地 ( 1 . 6 %トリブト ン、 1 %イーストエキストラクト、 0 . 5 %食塩) などを使用することができ、 当該培地に種菌を接種後、 3 0〜 5 0 °Cで 1 0〜 5 0時間程度必要により撹拌し ながら培養し、 得られた培養液を遠心分離して微生物菌体を集菌することにより キナーゼ活性を有する微生物菌体を調製することができる。  The cells of the microorganism can be prepared by using a medium in which the microorganism can grow, culturing by a conventional method, and collecting cells by centrifugation or the like. To be more specific, using E. coli as an example, the culture medium may be broth medium, LB medium (1% tryptone, 0.5% first extract, 1% salt) or 2XYT medium (1.6% Triton, 1% yeast extract, 0.5% salt) can be used.After inoculating the culture medium with the inoculum, stir at 30 to 50 ° C for about 10 to 50 hours if necessary. Microbial cells having kinase activity can be prepared by centrifuging the obtained culture solution and collecting the microbial cells.

微生物の菌体処理物としては、 上記微生物菌体を機械的破壊 (ワーリングブレ ンダ一、 フレンチプレス、 ホモジナイザー、 乳鉢などによる) 、 凍結融解、 自己 消化、 乾燥 (凍結乾燥、 風乾などによる) 、 酵素処理 (リゾチームなどによる) 、 超音波処理、 化学処理 (酸、 アルカリ処理などによる) などの一般的な処理法に 従って処理して得られる菌体の破壊物または菌体の細胞壁もしくは細胞膜の変性 物を例示することができる。  Microbial cell processed products include mechanical destruction of the above microbial cells (using a Waring blender, French press, homogenizer, mortar, etc.), freeze-thawing, self-digestion, drying (freeze-drying, air-drying, etc.), enzymes Destruction of cells or denaturation of cell walls or cell membranes obtained by treatment according to general treatment methods such as treatment (eg, with lysozyme), ultrasonic treatment, or chemical treatment (eg, with acid or alkali). Can be exemplified.

酵素調製物としては、 上記菌体処理物から当該酵素活性を有する画分を通常の 酵素の精製手段 (塩析処理、 等電点沈澱処理、 有機溶媒沈澱処理、 透析処理、 各 種クロマトグラフィ一処理など) を施して得られる粗酵素または精製酵素を例示 することができる。  As the enzyme preparation, a fraction having the enzyme activity from the treated cells is purified by a conventional enzyme purification method (salt-out treatment, isoelectric point precipitation, organic solvent precipitation, dialysis, various types of chromatography) And the like).

本発明で使用する糖としては、 目的とする糖ヌクレオチドに応じてガラクトー ス、 グルクロン酸、 ガラクッロン酸、 ァラビノース、 フコースなどが挙げられ、 これらは市販のものを使用することができる。 使用濃度としては約 1〜2 0 0 mM、 好ましくは約 1 0〜1 0 OmMの範囲から適宜設定できる。 Examples of the sugar used in the present invention include galactose, glucuronic acid, galacturonic acid, arabinose, fucose and the like depending on the target sugar nucleotide. These can use a commercial thing. The concentration used can be appropriately set within a range of about 1 to 200 mM, preferably about 10 to 10 OmM.

また、 リン酸の供与体としては ATPを使用することができる。 ATPも市販 品を使用すればよく、 使用濃度としては糖濃度に対応し、 約 1〜2 0 OmM, 好 ましくは約 1 0〜1 0 OmMの範囲から適宜設定できる。 また、 一般に ATPは 高価であるため、 ポリリン酸をリン酸ドナーとしたポリリン酸キナーゼを用いた ATP再生系も併用可能である。  ATP can be used as a phosphoric acid donor. ATP may also be a commercially available product, and the concentration used can be appropriately set in the range of about 1 to 20 OmM, preferably about 10 to 10 OmM, corresponding to the sugar concentration. Since ATP is generally expensive, an ATP regeneration system using polyphosphate kinase using polyphosphate as a phosphate donor can also be used.

糖 1一リン酸の合成反応は、 上記キナーゼ、 糖及び ATPもしくは ATP再生 系以外に約 5〜2 OmMの範囲でマグネシウムイオン、 亜鉛イオン等の酵素に応 じた無機イオンを添加し、 約 pH 5. 0〜9. 0の範囲の適当な緩衝液中、 約 1 0〜 5 0°C、 好ましくは 3 0〜 4 0 °Cの範囲で実施することができる。  In the synthesis reaction of sugar monophosphate, inorganic ions corresponding to enzymes such as magnesium ion and zinc ion are added in the range of about 5 to 2 OmM in addition to the above kinase, sugar and ATP or ATP regeneration system, and the pH is adjusted to about pH. It can be carried out in a suitable buffer in the range of 5.0 to 9.0 at about 10 to 50 ° C, preferably in the range of 30 to 40 ° C.

このようにして得られた糖 1—リン酸は、 通常の単離精製手段 (イオン交換ク 口マトグラフィー、 吸着クロマトグラフィー、 塩析など) により簡単に単離精製 することができる。  The sugar 1-phosphate thus obtained can be easily isolated and purified by ordinary isolation and purification means (eg, ion exchange chromatography, adsorption chromatography, salting out, etc.).

次に、 糖 1—リン酸とヌクレオシド 5' —モノリン酸との化学的縮合反応は公 知の方法に従って実施すればよい。 具体的にはジシクロへキシルカルポジイミ ド (DCC) を用いる方法 ( Am. Chem. So , 80, 3756(1958)) 、 モルホリデ ート法 ( Am. Chem. So , 83, 659(1961)) 、 ァニオン交換法 (Biochim. Biop ys. Acta, 91, 1-13(1964) 、 特公昭 4 9 - 1 0 6 74号公報、 特公昭 5 1 - 3 9 22 7号公報) 等を例示することができ、 この中でも特にァニオン交換法 が好適である。 縮合反応の反応条件等は、 上記文献の記載に従って行えばよい。 このようにして得た糖ヌクレオチドは、 通常の単離精製手段 (イオン交換クロ マトグラフィー、 吸着クロマトグラフィー、 塩析など) により単離精製すること ができる。 実施例 次に、 実施例を挙げて本発明を詳細に説明するが、 本発明にはこれに何ら限定 されるものではない。 Next, the chemical condensation reaction between sugar 1-phosphate and nucleoside 5'-monophosphate may be carried out according to a known method. Specifically, a method using dicyclohexyl carpoimide (DCC) (Am. Chem. So, 80, 3756 (1958)), a morpholidate method (Am. Chem. So, 83, 659 (1961)) , Anion exchange method (Biochim. Biopys. Acta, 91, 1-13 (1964), Japanese Patent Publication No. 49-10674, Japanese Patent Publication No. 51-39227), etc. Among them, the anion exchange method is particularly preferable. The reaction conditions and the like for the condensation reaction may be performed according to the description in the above-mentioned literature. The sugar nucleotide thus obtained can be isolated and purified by ordinary isolation and purification means (eg, ion exchange chromatography, adsorption chromatography, salting out, etc.). Example Next, the present invention will be described in detail with reference to examples, but the present invention is not limited thereto.

実施例 1 Example 1

( 1 ) 大腸菌ガラクトキナ一ゼの調製  (1) Preparation of Escherichia coli galactokinase

1 Om^の 1 00 g/m£のアンピシリ ンを含む 2 xYT ( 1. 6%トリプ トン、 1 %イーストエキストラクト、 0. 5 %食塩) 培地に一白金耳の g a 1 K 遺伝子 (Nucleic Acid Res, 13, 1841 (1985))が組み込まれたプラスミ ド、 pDR 540 (Gene, 20, 231 (1982)、 Pharmacia社より入手) を保持する大腸 菌 JM1 05 (Pharmacia社より入手) を植菌して、 37°Cにて 1 6時間振とう 培養した。 これを前培養菌体として 200 Om^容フラスコに入った 50 Omぶ の 2 xYT培地に植菌して 30°Cにて 2時間振とう培養した。 次に終濃度 0. 5 mMとなるようにィソプロピル — D—チォガラクトビラノシドを添加し、 さら に 5時間、 3 0°Cにて振とう培養を続けた。 培養液から遠心分離によって菌 体を回収し、 5 Om^の緩衝液 (5 OmM トリス塩酸 (pH 7. 8) 、 1 mM EDTA) に菌体を懸濁したのち、 超音波破砕処理により菌体を破砕した。 遠心 分離により得た上清を酵素液とした。  One platinum loop of the ga1K gene (Nucleic Acid) containing 1 Om ^ of 100 g / m £ ampicillin in 2 x YT (1.6% tryptone, 1% yeast extract, 0.5% salt) medium Res., 13, 1841 (1985)), and inoculated with Escherichia coli JM105 (obtained from Pharmacia) harboring pDR540 (Gene, 20, 231 (1982), obtained from Pharmacia). And cultured with shaking at 37 ° C for 16 hours. This was used as a precultured cell and inoculated into 50 Om of 2 x YT medium in a 200 Om ^ flask, and cultured with shaking at 30 ° C for 2 hours. Next, isopropyl-D-thiogalactobilanoside was added to a final concentration of 0.5 mM, and shaking culture was continued for further 5 hours at 30 ° C. The cells are collected from the culture by centrifugation, suspended in 5 Om ^ buffer (5 OmM Tris-HCl (pH 7.8), 1 mM EDTA), and then disrupted by sonication. Was crushed. The supernatant obtained by centrifugation was used as an enzyme solution.

回収された 5 Om の粗酵素液には 1 5ュニッ 卜/ m のガラクトキナ一ゼ活 性が含まれており、 タンパク質あたりの活性は 1. 3ユニッ ト/ mgであった c なお、 ガラクトキナ一ゼ活性の単位 (ュニッ ト) は、 以下に示す方法で測定、 算出したものである。  The recovered 5 Om crude enzyme solution contained 15 units / m of galactokinase activity, and the activity per protein was 1.3 units / mg. The unit of activity (unit) is measured and calculated by the following method.

(ガラクトキナ一ゼ活性の測定と単位の算出法)  (Measurement of galactokinase activity and calculation of units)

5mM 塩化マグネシウム、 1 OmM ガラクト一ス、 1 0 mM ATPを含 む 1 00 mM トリス塩酸緩衝液 ( p H 7. 8) に適当量の酵素標品を添加し、 Add an appropriate amount of enzyme preparation to 100 mM Tris-HCl buffer (pH 7.8) containing 5 mM magnesium chloride, 1 OmM galactose, and 10 mM ATP.

37°Cで保温後、 1 00°Cで 1分間の熱処理により酵素を失活させる。 ダイォネ クス (D I ONEX) 糖分析装置を用いて反応液中のガラクトース 1ーリン酸濃 度を定量する。 この条件で 1分間に 1マイクロモルのガラクト一ス 1ーリン酸を 生成する活性を 1ユニッ トと定義した。 After incubating at 37 ° C, the enzyme is inactivated by heat treatment at 100 ° C for 1 minute. Quantify the concentration of galactose 1-phosphate in the reaction solution using a DI ONEX sugar analyzer. Under these conditions, 1 micromol of galactose-monophosphate per minute The generated activity was defined as one unit.

(2) ガラクト一ス 1—リン酸 (Ga _g— 1— P) の合成  (2) Synthesis of galactose 1-phosphate (Ga _g— 1—P)

5. 0 容ビ一カーに約 1. 0 ^の脱イオン水を入れ、 9 6. 9 1 gのトリス (ヒドキシメチル) ァミノメタン、 5 0 OmMの塩化マグネシウム溶液 2 Om_g、 3 6. 0 3 gのガラクトースおよび 2 9. 7 gの AT Pを加え、 溶解後 6 N塩酸 で pH7. 9に調整し、 2. 0 ^にフィルアップした。 3 7 °C水浴中でプレイン キュベート後、 これにガラク トキナ一ゼ液を 0. 5 UZm^になるよう加え、 3 7 °C水浴中でインキュベートした。 ダイォネクス糖分析装置で反応率を確認し、 2時間 3 0分後、 8 0°C達温により酵素反応を停止した。 3. 0 βπι MF濾過 により変成タンパク質沈殿を濾去し、 酵素反応液 2. 2 £を得た。  Add about 1.0 ^ of deionized water to a 5.0-volume vial, add 96.91 g of tris (hydroxymethyl) aminoaminomethane, 50 OmM magnesium chloride solution 2 Om_g, 36.0 3 g Galactose and 29.7 g of ATP were added, and after dissolution, the mixture was adjusted to pH 7.9 with 6 N hydrochloric acid and filled up to 2.0 ^. After pre-incubation in a 37 ° C water bath, a galactokinase solution was added thereto to a concentration of 0.5 UZm ^ and incubated in a 37 ° C water bath. The reaction rate was confirmed with a Dionex sugar analyzer, and after 2 hours and 30 minutes, the enzyme reaction was stopped when the temperature reached 80 ° C. The denatured protein precipitate was filtered off by 3.0 βπι MF filtration to obtain 2.2 £ of an enzyme reaction solution.

次に酵素反応液 2. 2 _gをァニオン交換樹脂カラムクロマトグラフィーにアブ ライし、 水洗後酢酸カリウム緩衝液 (pH 4. 7) により溶出し、 得られた Ga ^— 1— P画分に KOH溶液を滴下し pH7. 0に調整後、 濃縮した。 次に この濃縮液にアルコールを加え撹拌し、 ガラクトース 1ーリン酸カリウム塩を析 出させた。 この結晶を膜濾過により濾別後、 真空乾燥してガラクト一ス 1一リン 酸カリウム塩 4 1 g (純度 9 9. 9%) を得た。  Next, 2.2_g of the enzyme reaction mixture was aliquoted by anion exchange resin column chromatography, washed with water and eluted with potassium acetate buffer (pH 4.7). The solution was added dropwise, adjusted to pH 7.0, and concentrated. Next, alcohol was added to the concentrated solution, followed by stirring to precipitate potassium galactose 1-phosphate. The crystals were separated by membrane filtration and dried in vacuo to obtain 41 g of potassium galactose-11-phosphate (purity 99.9%).

(3) UDP— Ga ^の合成  (3) Synthesis of UDP—Ga ^

水にガラクトース 1—リン酸カリウム塩を溶解し、 これをカチオン交換樹脂力 ラムクロマトグラフィーに供し、 水で洗浄した。 得られた通過 ·水洗液にトリブ チルァミ ンを加え撹捽中和後、 減圧濃縮した。 乾固後、 ピリジンを加え再溶解し、 減圧濃縮した。 さらにもう一度ピリジンを加え再溶解し、 Ga _g— 1— Ρ · トリ — η—プチルァミン塩ピリジン溶液を得た。  Galactose 1-phosphate potassium salt was dissolved in water, and this was subjected to cation exchange resin column chromatography and washed with water. Tributylamine was added to the obtained passing and washing solution, neutralized by stirring, and then concentrated under reduced pressure. After drying, pyridine was added to redissolve and concentrated under reduced pressure. Further, pyridine was added again and redissolved to obtain a pyridine solution of Ga_g-1 -—- tri-η-butylamine.

UMP · トリ一η—プチルァミン塩 (8 Omm 0 ) の N, N—ジメチルァ セトアミ ド溶液 ( 4 0 m ^ ) にトリプチルァミン ( 1 0 1 mm 0 ^ ) およびジ ォキサンを加え、 さらに冷却下でジフヱ二ルリン酸クロリ ド ( 9 6mmo を加え 6 0分間反応後 P1—ゥリジン— 5' · P2—ジフヱニルピロリン酸溶液を 得た。 この溶液に G a _g— 1— P■ トリ— n—ブチルアミン塩のピリジン溶液を 加え、 室温で 60分間反応後、 水を添加して反応を停止した。 減圧下濃縮後、 酢 酸ェチルを加え撹拌し、 分液として水層を採取し、 濃縮した。 To a solution of UMP tri-η-butylamine (8 Omm 0) in N, N-dimethylacetamide (40 m ^) was added triptylamine (101 mm 0 ^) and dioxane. After adding 60 μm of phosphoric acid chloride and reacting for 60 minutes, the P 1 -peridine-5′P 2 -diphenylpyrophosphate solution was added. Obtained. A pyridine solution of G a _g-1 -P-tri-n-butylamine salt was added to the solution, and the mixture was reacted at room temperature for 60 minutes. The reaction was stopped by adding water. After concentration under reduced pressure, ethyl acetate was added and stirred, and an aqueous layer was collected as a liquid separation and concentrated.

(4) UDP— Ga ^の精製  (4) Purification of UDP-Ga ^

このようにして得られた合成液を希釈し、 ァニォン交換樹脂力ラムクロマトグ ラフィ一にアプライし、 水で洗浄後 N a C 溶液で UD P— G a ^を溶出した。 得られた UDP— Ga 画分を 1 N 塩酸を加え pH3. 0に調整し、 これを 粒状活性炭カラムに通過させ、 水で洗った後、 NaOH溶液で溶出した。 水洗お よび溶出液の中の UDP— G a ^を含む画分を集め、 pH6. 2に調整後減圧濃 縮した。 この液にアルコールを加え UDP— G a ^を沈殿させた。 この上澄をデ カンテーシヨンにより除き、 沈殿を水に溶解した。 減圧濃縮後、 凍結乾燥して 22. 4 gの UDP— Ga_gを得た。  The synthesis solution thus obtained was diluted, applied to an anion-exchange resin, Lamchromatography, washed with water, and eluted UDP-Ga ^ with a NaC solution. The obtained UDP-Ga fraction was adjusted to pH 3.0 by adding 1 N hydrochloric acid, passed through a granular activated carbon column, washed with water, and eluted with a NaOH solution. The fractions containing UDP-Ga ^ in the water washing and eluate were collected, adjusted to pH 6.2, and concentrated under reduced pressure. Alcohol was added to this solution to precipitate UDP-Ga ^. The supernatant was removed by decantation, and the precipitate was dissolved in water. After concentration under reduced pressure, the residue was freeze-dried to obtain 22.4 g of UDP-Ga_g.

実施例 2 Example 2

( 1 ) 大腸菌ポリリン酸キナーゼ遺伝子のクロ一ニング  (1) Cloning of Escherichia coli polyphosphate kinase gene

大腸菌 K 1 2株 JM1 09菌 (宝酒造 (株) より入手) の染色体 DNAを斉藤 と三浦の方法 (Biochim. Biophys. Acta., 72, 619 (1963)) で調製した。 この DNAをテンペレートとして、 以下に示す 2種類のプライマー DNAを常法に従 つて合成し、 PCR法により大腸菌ポリ リン酸キナーゼ (ppk) 遺伝子を増幅 した。  Chromosomal DNA of Escherichia coli K12 strain JM109 (obtained from Takara Shuzo Co., Ltd.) was prepared by the method of Saito and Miura (Biochim. Biophys. Acta., 72, 619 (1963)). Using this DNA as a template, the following two types of primer DNAs were synthesized according to a conventional method, and the Escherichia coli polyphosphate kinase (ppk) gene was amplified by PCR.

プライマー ( A ) : 5' -TACCATGGGTCAGGAAAAGCTATA-3'  Primer (A): 5'-TACCATGGGTCAGGAAAAGCTATA-3 '

プライマー ( B ) : 5' -ATGGATCCTTATTCAGGTTGTTCGAGTGA-3'  Primer (B): 5'-ATGGATCCTTATTCAGGTTGTTCGAGTGA-3 '

PCRによる ppk遺伝子の増幅は、 反応液 1 0 Om^中 (5 OmM 塩化力 リウ厶、 1 OmM トリス塩酸 (pH 8. 3) 、 1. 5mM 塩化マグネシウム、 0. 0 0 1 %ゼラチン、 テンペレート DNA 0. 1〃 g、 プライマー DNA (A) (B) 各々 0. 2〃M、 Amp l i Ta q DNAポリメラーゼ 2. 5 ュニッ ト) を P e r k i n— E lme r C e t u s I n s t r ume n t社 製 DNA The rma l C y c 1 e rを用いて、 熱変性 ( 94 °C、 1分) 、 アニーリ ング (55°C、 1. 5分) 、 ポリメライゼーシヨン (72° (、 1. 5 分) のステップを 25回繰り返すことにより行った。 Amplification of the ppk gene by PCR is performed in a reaction mixture of 10 Om ^ (5 OmM chloride, 1 OmM Tris-HCl (pH 8.3), 1.5 mM magnesium chloride, 0.01% gelatin, temperate 0.1 µg of DNA, 0.2 µM each of primer DNA (A) and (B), 2.5 units of Ampli Taq DNA polymerase) were added to Perkin—ElmerCetus Instrument Thermal denaturation (94 ° C, 1 minute), annealing (55 ° C, 1.5 minutes), polymerase (72 ° (1.5 minutes)) using DNA Thermal Cyc 1 er ) Was repeated 25 times.

遺伝子増幅後、 反応液をフヱノール Zクロ口ホルム (1 : 1)混合液で処理し、 水溶性画分に 2倍容のエタノ―ルを添加し D N Aを沈殿させた。 沈殿回収した DNAを文献 (Molecular Cloning. 前述) の方法に従ってァガロースゲル電気 泳動により分離し、 1. 0 kb相当の DNA断片を精製した。 該 DNAを制限酵 素 Nc 0 I及び BamH Iで切断し、 同じく制限酵素 N c o I及び BamH I で消化したプラスミ ド pTr c 99A (Pharmacia Biotech社より入手) と T 4 DNAリガーゼを用いて連結した。 連結反応液を用いて大腸菌 JM1 09菌 を形質転換し、 得られたァンピシリン耐性形質転換体よりプラスミ ド p T r c - PPKを単離した。 pTr c— PPKは、 pTr c 99Aの" t r cプロモーター 下流の Nc o I—BamH I切断部位に大腸菌 ppk遺伝子を含有する Nc o I -B amH I DNA断片が揷入されたものである。  After gene amplification, the reaction solution was treated with a mixed solution of phenol Z-cloth form (1: 1), and two times the volume of ethanol was added to the water-soluble fraction to precipitate DNA. The DNA collected by precipitation was separated by agarose gel electrophoresis according to the method described in the literature (Molecular Cloning, supra), and a DNA fragment corresponding to 1.0 kb was purified. The DNA was digested with restriction enzymes NcoI and BamHI and ligated with plasmid pTrc99A (obtained from Pharmacia Biotech), also digested with restriction enzymes NcoI and BamHI, using T4 DNA ligase. . Escherichia coli JM109 was transformed using the ligation reaction solution, and plasmid pTrc-PPK was isolated from the obtained ampicillin-resistant transformant. pTr c -PPK is obtained by inserting an Nco I -BamHI DNA fragment containing the E. coli ppk gene into the Nco I -BamHI cleavage site downstream of the "trc promoter of pTr c 99A.

(2)大腸菌ポリリン酸キナーゼの調製  (2) Preparation of E. coli polyphosphate kinase

プラスミ ド pTr c— PPKを保持する大腸菌 JM1 09菌を、 1 00〃gZ のアンピシリンを含有する 2 xYT培地 30 Om^に植菌し、 37°Cで振と う培養した。 4 X 1 08菌 Zm^に達した時点で、 培養液に終濃度 1 mMになる ように I PTGを添加し、 さらに 30°Cで 5時間振とう培養を続けた。 培養終了 後、 遠心分離 (9, 000 xg, 10分) により菌体を回収し、 60m の緩衝 液 (50mM トリス塩酸 (ρΗ 7. 5) 、 5mMEDTA、 0. 1 %トライト ン X— 1 00、 0. 2mgZm リゾチーム) に懸濁した。 37 °Cで 1時間保温 した後、 超音波処理を行い、 菌体を破砕し、 さらに遠心分離 (20, 000 xg. 1 0分) により菌体残さを除去した。 このように得られた上清画分を 5 mM 塩 化マグネシウム及び 1 mM 2—メルカプトエタノールを含有する 5 OmMトリ ス塩酸 (pH7. 8) に対して透析を行い、 粗酵素液とした。 粗酵素液におけるポリリン酸キナーゼ比活性は、 0. 1 9ュニット /mg蛋白 質であり、 対照菌 (pTr c 9 9 Aを保持する大腸菌 JM 1 0 9菌) の比活性Escherichia coli JM109 carrying the plasmid pTrc-PPK was inoculated into 2Om ^ of a 2 x YT medium containing 100 µg of ampicillin and cultured with shaking at 37 ° C. Once at the 4 X 1 0 8 bacteria Zm ^, was added I PTG to a final concentration of 1 mM to the culture solution was continued for an additional 5 hours with shaking cultured at 30 ° C. After completion of the culture, the cells were collected by centrifugation (9,000 xg, 10 minutes), and a 60-m buffer (50 mM Tris-HCl (ρΗ7.5), 5 mM EDTA, 0.1% Triton X-100, 0.2 mgZm lysozyme). After incubating at 37 ° C for 1 hour, the cells were sonicated to disrupt the cells, and centrifuged (20,000 xg, 10 minutes) to remove the cell residues. The supernatant fraction thus obtained was dialyzed against 5 OmM Tris-HCl (pH 7.8) containing 5 mM magnesium chloride and 1 mM 2-mercaptoethanol to obtain a crude enzyme solution. The specific activity of polyphosphate kinase in the crude enzyme solution is 0.19 units / mg protein, which is the specific activity of the control bacterium (Escherichia coli JM109 carrying pTrc99A).

(0. 0 0 0 1 8ュニット mg蛋白質) の約 1 0 0 0倍であった。 次に粗酵素 液を DEAEトヨパール 6 5 0 M (ト一ソ一 (株) ) を用いて 0〜0. 5M Na C£の濃度勾配にて分画し、 ポリリン酸キナーゼ画分を得た。 この画分をポ リリン酸キナーゼ酵素標品とした。 なお、 この酵素標品におけるポリリン酸キナ —ゼの比活性は、 0. 6ユニット/ mg蛋白質であった。 (0.00000 unit mg protein). Next, the crude enzyme solution was fractionated using DEAE Toyopearl 65 M (Tosoichi Co., Ltd.) with a concentration gradient of 0 to 0.5 M NaCp to obtain a polyphosphate kinase fraction. This fraction was used as a polyphosphate kinase enzyme preparation. The specific activity of polyphosphate kinase in this enzyme preparation was 0.6 unit / mg protein.

(3) 大腸菌アデニレ一トキナ一ゼのクローニング  (3) Cloning of E. coli adenylate tokinase

大腸菌 1 2株 JM1 0 9菌 (宝酒造 (株) より入手) の染色体 DNAを斉藤 と三浦の方法 (Biochim. Biophys. Acta. , 72, 619 (1963)) で調製した。 この DNAをテンペレートとして、 以下に示す 2種類のプライマ一 DNAを常法に従 つて合成し、 PCR法により大腸菌アデニレ一トキナ一ゼ (a dk) 遺伝子を増 幅した。  Chromosomal DNA of Escherichia coli 12 strain JM109 (obtained from Takara Shuzo Co., Ltd.) was prepared by the method of Saito and Miura (Biochim. Biophys. Acta., 72, 619 (1963)). Using this DNA as a template, the following two primer DNAs were synthesized according to a conventional method, and the E. coli adenylate tokinase (adk) gene was amplified by PCR.

プライマ一 ( C ) : 5' -ATGGATCCCGTTTCAGCCCCAGGTGCC-3'  Primer (C): 5'-ATGGATCCCGTTTCAGCCCCAGGTGCC-3 '

プライマー (D) : 5' -ATAAGCTTGGCCTGAGATTGCTGATAAG-3'  Primer (D): 5'-ATAAGCTTGGCCTGAGATTGCTGATAAG-3 '

PCRによる a dk遺伝子の増幅は、 反応液 1 O Om^中 (5 0mM 塩化力 リウ厶、 1 OmM トリス塩酸 (ρΗ8. 3) 、 1. 5 mM 塩化マグネシウム、 0. 0 0 1 %ゼラチン、 テンべレート DNA 0. 1 g、 プライマ一 DNA (C) (D) 各々 0. l〃M、 Amp l i Ta q DNAポリメラ一ゼ 2. 5ュ ニット > ¾rP e r k i n— E l me r C e t υ s I n s t r ume n t社製 DNA Th e rma l C y c 1 e rを用いて、 熱変性 ( 9 4 °C、 1分) 、 ァ ニーリング (5 6°C、 1. 0分) 、 ポリメライゼ一シヨン (72°C、 3. 0分) のステップを 25回繰り返すことにより行った。 遺伝子増幅後、 反応液をフエ ノール Zクロ口ホルム ( 1 : 1 ) 混合液で処理し、 水溶性画分に 2倍容のェタノ —ルを添加し DNAを沈殿させた。 沈殿回収した DNAを文献 (Molecular cloning、 前述) の方法に従ってァガロースゲル電気泳動により分離し、 1. 0 kb相当の DNA断片を精製した。 該 DNAを制限酵素 B amH I及び H i n d 1で切断し、 同じく制限酵素 B amH I及び H i n dillで消化したプラスミ ド pUC 1 8 (宝酒造 (株) より入手) と T 4 DN Aリガーゼを用いて連結した。 連結反応液を用いて大腸菌 JM1 09菌を形質転換し、 得られたアンピシリン耐 性形質転換体よりプラスミ ド pUC— ADKを単離した。 pUC— ADKは、 p UC 1 8の 1 a cプロモーター下流の B amH I— H i n d IE切断部位に大腸菌 a d k遺伝子を含有する B amH I -H i n dl DNA断片が挿入されたもの である。 The amplification of the adk gene by PCR was performed in a reaction mixture of 1 O Om ^ (50 mM chloride, 1 OmM tris-hydrochloride (ρΗ8.3), 1.5 mM magnesium chloride, 0.01% gelatin, Belate DNA 0.1 g, Primer DNA (C) (D) 0.1 M each, Ampli Taq DNA polymerase 2.5 units> ¾rPerkin—ElmerCetυS I Thermal denaturation (94 ° C, 1 minute), annealing (56 ° C, 1.0 minute), polymerase (72 ° C) using DNA Thermal Cyc 1 er manufactured by nstrument (C, 3.0 minutes) was repeated 25 times.After gene amplification, the reaction solution was treated with a mixture of phenol Z-cloth form (1: 1) and doubled to the water-soluble fraction. The precipitated DNA was separated by agarose gel electrophoresis according to the method described in the literature (Molecular cloning, described above), and the DNA was precipitated. A DNA fragment corresponding to kb was purified. The DNA was cleaved with restriction enzymes BamHI and Hind1, and plasmid pUC18 (obtained from Takara Shuzo Co., Ltd.) and T4DNA ligase digested with restriction enzymes BamHI and Hindill were also used. Connected. Escherichia coli JM109 was transformed using the ligation reaction solution, and plasmid pUC-ADK was isolated from the resulting ampicillin-resistant transformant. pUC-ADK is obtained by inserting a BamHI-HindI DNA fragment containing the E. coli adk gene into the BamHI-HindIE cleavage site downstream of the 1 ac promoter of pUC18.

(4)大腸菌アデ二レートキナーゼの調製  (4) Preparation of E. coli adenylate kinase

プラスミ ド pUC— ADKを保持する大腸菌 JM 1 09菌を、 1 00〃gZ のアンピシリンを含有する 2 xYT培地 30 Om^に植菌し、 37°Cで振と う培養した。 4 X 1 08菌 Zm£に達した時点で、 培養液に終濃度 ImMになる ように I PTGを添加し、 さらに 30°Cで 5時間振とう培養を続けた。 培養終了 後、 遠心分離 (9, 000 xg, 10分) により菌体を回収し、 60m の緩衝 液 (50mM トリス塩酸 (pH 7. 5) 、 5 mM EDTA、 0. 1%トライ トン X— 100、 0. 2mgZm^リゾチーム) に懸濁した。 37でで 1時間保 温した後、 超音波処理を行い、 菌体を破砕し、 さらに遠心分離 ( 20, 000 X g、 1 0分) により菌体残さを除去した。 Escherichia coli JM109 carrying plasmid pUC-ADK was inoculated into 30 Om ^ of 2 x YT medium containing 100 µg of ampicillin, and cultured at 37 ° C with shaking. When the culture reached 4 × 10 8 Zm, IPTG was added to the culture solution to a final concentration of ImM, and shaking culture was further continued at 30 ° C. for 5 hours. After completion of the culture, the cells were collected by centrifugation (9,000 xg, 10 minutes), and a 60-m buffer (50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 0.1% Triton X—100 , 0.2 mg Zm ^ lysozyme). After incubating for 1 hour at 37, the cells were sonicated to disrupt the cells, and centrifuged (20,000 xg, 10 minutes) to remove cell residues.

このように得られた上清画分を 5 mM 塩化マグネシウム及び ImM 2—メ ルカプトエタノールを含有する 5 OmMトリス塩酸 (pH7. 8) に対して透析 を行い、 粗酵素液とした。 粗酵素液におけるアデ二レートキナーゼの比活性は、 1 34ュニット Zmg蛋白質であり、 対照菌 (pUC 1 8を保持する大腸菌 JM 1 09菌) の比活性 (1. 9ュニット /mg蛋白質) の約 85倍であった。 次に 粗酵素液を DEAEトヨパール 650 M (トーソ一 (株) ) を用いて 0〜0. 5 M Na の濃度勾配にて分画し、 アデ二レートキナーゼ活性のある画分を回 収した。 この画分をアデ二レートキナーゼ酵素標品とした。 なお、 この酵素標品 におけるポリリン酸キナーゼの比活性は、 344ュニッ ト/ mg蛋白質であった cThe supernatant fraction thus obtained was dialyzed against 5 OmM Tris-HCl (pH 7.8) containing 5 mM magnesium chloride and ImM2-mercaptoethanol to obtain a crude enzyme solution. The specific activity of adenylate kinase in the crude enzyme solution is 134 units Zmg protein, which is about the same as the specific activity (1.9 units / mg protein) of the control bacterium (Escherichia coli JM109 carrying pUC18). It was 85 times. Next, the crude enzyme solution was fractionated using DEAE Toyopearl 650 M (Tosoichi Co., Ltd.) with a concentration gradient of 0.5 to 0.5 M Na, and a fraction having adenylate kinase activity was collected. This fraction was used as an adenylate kinase enzyme preparation. In addition, this enzyme preparation The specific activity of polyphosphate kinase in was 344 units / mg protein.c

(5) ポリリン酸キナーゼとアデ二レートキナ一ゼによる ATP再生とガラクト キナーゼによるガラクトース 1ーリン酸の合成 (5) ATP regeneration by polyphosphate kinase and adenylate kinase and synthesis of galactose 1-phosphate by galactokinase

1 OmM 塩化マグネシウム、 1 0 OmM 硫安、 ポリリン酸 (無機リン酸と して 75mM) 及び 4mM AMPを含有する 1 0 0 mM トリス塩酸緩衝液 (pH 7. 8) に 0. 1ユニッ ト/ ポリ リン酸キナーゼ及び 2. 5ユニッ ト Zm^Tデニレートキナーゼ酵素標品を添加し、 37°Cで 1 20分保温した。 該 AMPリン酸化反応終了時の反応液中のヌクレオチド濃度は、 AT P 1. 4 m , ADP 1. 7mM、 AMP 0. 9mMであった。 この反応液に終濃度 4 OmMとなるように D ( + ) ガラクトースを添加し、 さらに 1. 0ユニッ ト/ となるようにガラクトキナ一ゼを添加し、 37°Cで 4. 5時間保温した。 反 応終了液を糖分析装置 (ダイォネックス社) を用いて分析したところ、 28. 4 mMのガラクトース 1ーリン酸の生成が確認された。  0.1 unit / polyphosphoric acid in 100 mM Tris-HCl buffer (pH 7.8) containing 1 OmM magnesium chloride, 10 OmM ammonium sulfate, polyphosphoric acid (75 mM as inorganic phosphoric acid) and 4 mM AMP Acid kinase and 2.5 units of Zm ^ T denylate kinase enzyme preparation were added, and the mixture was incubated at 37 ° C for 120 minutes. The nucleotide concentrations in the reaction solution at the end of the AMP phosphorylation reaction were ATP 1.4 m, ADP 1.7 mM, and AMP 0.9 mM. To this reaction solution, D (+) galactose was added to a final concentration of 4 OmM, and galactokinase was further added to 1.0 unit /, followed by incubation at 37 ° C for 4.5 hours. When the reaction-terminated liquid was analyzed using a sugar analyzer (Dionex), the production of 28.4 mM galactose 1-phosphate was confirmed.

(6) UDP— Ga の合成  (6) UDP-Ga synthesis

このようにして調製したガラクト一ス 1ーリン酸を実施例 1と同様に処理して UDP— G a を調製した。 産業上の利用可能性  The thus prepared galactose monophosphate was treated in the same manner as in Example 1 to prepare UDP-Ga. Industrial applicability

本発明の方法のように、 糖 1 -リン酸の合成をキナーゼを用いた酵素反応で行 うことにより、 目的とする糖 1一リン酸を簡便にしかも収率よく調製でき、 しか も合成した糖 1一リン酸は簡便な手段で容易に単離精製することができ、 純度の 高い糖 1―リン酸を得ることができる。 このような純度の高い糖 1―リン酸を用 いて化学的縮合反応を行うと、 目的とする糖ヌクレオチドも収率よく得ることが 可能で、 得られた糖ヌクレオチドの単離精製も容易である。  By synthesizing sugar 1-phosphate by an enzyme reaction using a kinase as in the method of the present invention, the desired sugar 1-monophosphate can be prepared simply and in good yield, and Sugar monophosphate can be easily isolated and purified by simple means, and high purity sugar 1-phosphate can be obtained. When a chemical condensation reaction is performed using such high-purity sugar 1-phosphate, the target sugar nucleotide can be obtained in good yield, and the obtained sugar nucleotide can be easily isolated and purified. .

したがって、 本発明の方法は、 糖ヌクレオチドの現実的でしかも実用的な方法 といえる。  Therefore, the method of the present invention can be said to be a practical and practical method for sugar nucleotides.

Claims

請 求 の 範 囲 . キナーゼを用いて糖をリン酸化して糖 1 一リン酸を調製し、 得られた糖 1 一 リン酸とヌクレオシド 5 ' —モノリン酸とから化学的縮合法により糖ヌクレオ チドを調製することを特徴とする、 糖ヌクレオチドの製造方法。 Scope of the request. Sugar is phosphorylated using a kinase to prepare sugar monophosphate, and then the sugar nucleotide is chemically condensed from the obtained sugar monophosphate and nucleoside 5'-monophosphate. Or a method for producing a sugar nucleotide. . キナーゼがガラクトキナ一ゼであり、 糖がガラクトースであり、 糖 1—リン 酸がガラクトース 1—リン酸であり、 ヌクレオシド 5 ' —モノリン酸がゥリジ ン 5 ' —モノリン酸であり、 糖ヌクレオチドがゥリジン二リン酸一ガラクトー スである、 請求項 1記載の方法。Kinase is galactokinase, sugar is galactose, sugar 1-phosphate is galactose 1-phosphate, nucleoside 5'-monophosphate is peridine 5'-monophosphate, and sugar nucleotide is peridine 2. The method according to claim 1, which is mono-galactose diphosphate. . キナーゼを用いて糖をリン酸化して糖 1 一リン酸を調製する工程が、 ポリ リ ン酸をリン酸ドナーとしたポリリン酸キナーゼを用いた A T P再生系を併用し たものである、 請求項 1記載の方法。The step of preparing a sugar monophosphate by phosphorylating a sugar using a kinase uses an ATP regeneration system using a polyphosphate kinase using polyphosphate as a phosphate donor. The method of paragraph 1. . 化学的縮合法が、 ジシクロへキシルカルポジイミ ドを用いる方法、 モルホリ デート法およびァニォン交換法から選択された方法である請求項 1記載の方 法。 The method according to claim 1, wherein the chemical condensation method is a method selected from a method using dicyclohexylcarpoimide, a morpholidate method and an anion exchange method.
PCT/JP1998/004895 1997-11-07 1998-10-29 Process for preparing sugar nucleotide Ceased WO1999024600A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32207797 1997-11-07
JP9/322077 1997-11-07

Publications (1)

Publication Number Publication Date
WO1999024600A1 true WO1999024600A1 (en) 1999-05-20

Family

ID=18139669

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP1998/004895 Ceased WO1999024600A1 (en) 1997-11-07 1998-10-29 Process for preparing sugar nucleotide

Country Status (1)

Country Link
WO (1) WO1999024600A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4738981A (en) * 1971-04-20 1972-12-06
JPS4882087A (en) * 1972-02-07 1973-11-02

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4738981A (en) * 1971-04-20 1972-12-06
JPS4882087A (en) * 1972-02-07 1973-11-02

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ENCYCLOPAEDIA CHIMICA, XX, XX, 30 March 1960 (1960-03-30), XX, pages 804/805, XP002920621 *
MARUO F., ET AL.: "GALACTOKINASE.", ENZYME HANDBOOK, SN, JP, 1 December 1982 (1982-12-01), JP, pages 332/333., XP002920622 *

Similar Documents

Publication Publication Date Title
US9193958B2 (en) Method of enzymatically synthesizing 3′-phosphoadenosine-5′-phosphosulfate
JP3545424B2 (en) Method for producing nucleoside 5'-triphosphate and its application
Elling et al. Expression, purification and characterization of recombinant phosphomannomutase and GDP-α-D-mannose pyrophosphorylase from Salmonella enterica, group B, for the synthesis of GDP-α-D-mannose from D-mannose
US6040158A (en) Process for preparing sugar nucleotide
JP3764755B2 (en) "Production Method of Adenosine 5'-Triphosphate and Its Application"
KR101123062B1 (en) Method of producing uridine 5'-diphospho-N-acetylgalactosamine
CA2492838A1 (en) Process for producing cmp-n-acetylneuraminic acid
JP4601060B2 (en) Azido amino sugar nucleotides and their applications
JPWO1998048031A1 (en) Method for producing adenosine 5'-triphosphate and its applications
JP3545425B2 (en) Method for producing uridine diphosphate-N-acetylglucosamine
WO1999024600A1 (en) Process for preparing sugar nucleotide
CA2392463C (en) Novel use of uridine diphosphate glucose 4-epimerase
JP2003093091A (en) Method for producing cmp-n-acetylneuraminic acid
JPWO1999024600A1 (en) Method for producing sugar nucleotides
JP2001169797A (en) Method for enzymatically producing s-adenosyl-l- methionine
JP2002085087A (en) Method for producing cytidine 5'-triphosphate and its application
JP4509447B2 (en) High purity guanosine 5'-diphosphate fucose and process for producing the same
JP2000041695A (en) Enzymatic production of 3-adenosyl-l-methionine
CN116479074A (en) A method for synthesizing rare sugar nucleotides by GDP-Mannose
JP2000217593A (en) Enzymatic production of cytidine 5'-triphosphate and their use
ZINCHENKO AI BERESNEV1, SV KVACH1, GG SIVETS2*, and
WO2006088017A1 (en) Sugar chain containing 4-position halogenated galactose and application thereof
WO2008140887A1 (en) Nucleotidyltransferases with enhanced nucleotide triphosphate flexibility

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09367630

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: KR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA